Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Staib

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Blood|June 19, 2002
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual diseaseSusanne Schnittger, Claudia Schoch, Martin Dugas, et al.
Microbial Pathogenesis|January 29, 2002
Individual acid aspartic proteinases (Saps) 1-6 of Candida albicans are not essential for invasion and colonization of the gastrointestinal tract in miceMarianne Kretschmar, Angelika Felk, Peter Staib, et al.
Plos One|April 25, 2013
Global transcriptome sequencing identifies chlamydospore specific markers in Candida albicans and Candida dubliniensisKatja Palige, Jörg Linde, Ronny Martin, et al.
European Journal of Cell Biology|November 8, 2005
Phospho-eNOS Ser-114 in human mesenchymal stem cells: constitutive phosphorylation, nuclear localization and upregulation during mitosisFranz-Josef Klinz, Annette Schmidt, Timo Schinköthe, et al.
Chemmedchem|November 18, 2010
New cis-configured aziridine-2-carboxylates as aspartic acid protease inhibitorsChristian Büchold, Yasmin Hemberger, Cornelia Heindl, et al.
Eukaryotic Cell|February 19, 2013
Factors supporting cysteine tolerance and sulfite production in Candida albicansFlorian Hennicke, Maria Grumbt, Ulrich Lermann, et al.
Blood|August 24, 2012
A novel hierarchical prognostic model of AML solely based on molecular mutationsVera Grossmann, Susanne Schnittger, Alexander Kohlmann, et al.
Stem Cells (Dayton, Ohio)|July 11, 2006
Basic fibroblast growth factor controls migration in human mesenchymal stem cellsAnnette Schmidt, Dennis Ladage, Timo Schinköthe, et al.
Haematologica|August 24, 2011
Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patientsMaria J G T Vehreschild, Arne M K Meissner, Oliver Andreas Cornely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2005
Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trialThomas Elter, Peter Borchmann, Holger Schulz, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Blood|June 19, 2002
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual diseaseSusanne Schnittger, Claudia Schoch, Martin Dugas, et al.
Microbial Pathogenesis|January 29, 2002
Individual acid aspartic proteinases (Saps) 1-6 of Candida albicans are not essential for invasion and colonization of the gastrointestinal tract in miceMarianne Kretschmar, Angelika Felk, Peter Staib, et al.
Plos One|April 25, 2013
Global transcriptome sequencing identifies chlamydospore specific markers in Candida albicans and Candida dubliniensisKatja Palige, Jörg Linde, Ronny Martin, et al.
European Journal of Cell Biology|November 8, 2005
Phospho-eNOS Ser-114 in human mesenchymal stem cells: constitutive phosphorylation, nuclear localization and upregulation during mitosisFranz-Josef Klinz, Annette Schmidt, Timo Schinköthe, et al.
Chemmedchem|November 18, 2010
New cis-configured aziridine-2-carboxylates as aspartic acid protease inhibitorsChristian Büchold, Yasmin Hemberger, Cornelia Heindl, et al.
Eukaryotic Cell|February 19, 2013
Factors supporting cysteine tolerance and sulfite production in Candida albicansFlorian Hennicke, Maria Grumbt, Ulrich Lermann, et al.
Blood|August 24, 2012
A novel hierarchical prognostic model of AML solely based on molecular mutationsVera Grossmann, Susanne Schnittger, Alexander Kohlmann, et al.
Stem Cells (Dayton, Ohio)|July 11, 2006
Basic fibroblast growth factor controls migration in human mesenchymal stem cellsAnnette Schmidt, Dennis Ladage, Timo Schinköthe, et al.
Haematologica|August 24, 2011
Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patientsMaria J G T Vehreschild, Arne M K Meissner, Oliver Andreas Cornely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2005
Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trialThomas Elter, Peter Borchmann, Holger Schulz, et al.
Pageof 9